SCHEMBL19995530

SCHEMBL19995530

O=CC1CC(c2ccccc2)CN1C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AKR1C3 P42330 1/20 0.41
▸ AKR1C1 Q04828 1/20 0.41
▸ GRIN2B Q13224 3/20 0.40
▸ ALDH1A1 P00352 3/20 0.40
▸ POLB P06746 2/20 0.40
▸ KMT2A Q03164 2/20 0.38
▸ NPC1 O15118 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ RIPK1 Q13546 1/20 0.38
▸ TP53 P04637 2/20 0.37
▸ SIGMAR1 Q99720 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HCRTR2 O43614 1/20 0.37
▸ BRD4 O60885 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27275008 0.82 HCRTR2 (0.47) ALDH1A1KMT2AGAAMAPTMEN1
SCHEMBL20005947 0.80 HTRA1 (0.50) KMT2AMEN1HCRTR2
SCHEMBL21053051 0.80 HCRTR2 (0.33) RIPK1HCRTR2
SCHEMBL12604444 0.78 BRD4 (0.38) AKR1C3AKR1C1GRIN2BALDH1A1POLB
SCHEMBL9980195 0.78 BRD4 (0.38) AKR1C3AKR1C1GRIN2BALDH1A1POLB
SCHEMBL25362718 0.77 AKR1C3 (0.41) AKR1C3AKR1C1GRIN2BALDH1A1POLB
SCHEMBL5576810 0.77 AKR1C3 (0.41) AKR1C3AKR1C1GRIN2BALDH1A1POLB
SCHEMBL25362834 0.77 AKR1C3 (0.41) AKR1C3AKR1C1GRIN2BALDH1A1POLB
SCHEMBL25363009 0.76 AKR1C3 (0.47) AKR1C3AKR1C1GRIN2BALDH1A1
SCHEMBL6695511 0.76 AKR1C3 (0.47) AKR1C3AKR1C1GRIN2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515433-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2019-07-31 — — EP disclosed
WO-2018056854-A1 BLOOD-BRAIN BARRIER-PENETRANT DOPAMINE-B-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2018-03-29 — — WO disclosed
Send feedback